MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects
- PMID: 23797816
- DOI: 10.1007/s13277-013-0940-7
MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects
Abstract
MicroRNAs (miRNAs) are small RNA molecules, which can interfere with the expression of several genes and act as gene regulator. miRNAs have been proved as a successful diagnostic and therapeutic tool in several cancers. In this review, the differential expression of miRNAs in osteosarcoma and their possibility to be used as diagnostic and therapeutic tools have been discussed. Osteosarcoma is the most common primary bone tumor that mainly affects children and adolescents. The current treatment of osteosarcoma remains difficult, and osteosarcoma causes many deaths because of its complex pathogenesis and resistance to conventional treatments. Several studies demonstrated that the differential expression patterns of miRNAs are a promising tool for the diagnosis and treatment of osteosarcoma. Although some aspect of the mechanism of action of miRNAs in controlling osteosarcoma has been identified (e.g., targeting the Notch signaling pathway), it is far beyond to the clear understanding of miRNA targets in osteosarcoma. Identification of the specific target of miRNAs may aid molecular targets for drug development and future relief of osteosarcoma.
Similar articles
-
Biological analysis of cancer specific microRNAs on function modeling in osteosarcoma.Sci Rep. 2017 Jul 14;7(1):5382. doi: 10.1038/s41598-017-05819-7. Sci Rep. 2017. PMID: 28710380 Free PMC article.
-
Involvement and Clinical Aspects of MicroRNA in Osteosarcoma.Int J Mol Sci. 2016 Jun 3;17(6):877. doi: 10.3390/ijms17060877. Int J Mol Sci. 2016. PMID: 27271607 Free PMC article. Review.
-
MicroRNA signatures in osteosarcoma: diagnostic insights and therapeutic prospects.Mol Cell Biochem. 2025 Apr;480(4):2065-2075. doi: 10.1007/s11010-024-05135-5. Epub 2024 Oct 17. Mol Cell Biochem. 2025. PMID: 39419925 Free PMC article. Review.
-
MicroRNAs Implications in the Onset, Diagnosis, and Prognosis of Osteosarcoma.Curr Mol Med. 2021;21(7):573-588. doi: 10.2174/1566524020999201203212824. Curr Mol Med. 2021. PMID: 33272173 Review.
-
Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.J Cell Biochem. 2019 Jun;120(6):9656-9666. doi: 10.1002/jcb.28244. Epub 2018 Dec 11. J Cell Biochem. 2019. PMID: 30548308
Cited by
-
SRCIN1 Suppressed Osteosarcoma Cell Proliferation and Invasion.PLoS One. 2016 Aug 11;11(8):e0155518. doi: 10.1371/journal.pone.0155518. eCollection 2016. PLoS One. 2016. Retraction in: PLoS One. 2023 Mar 29;18(3):e0282984. doi: 10.1371/journal.pone.0282984. PMID: 27513473 Free PMC article. Retracted.
-
MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.BMC Cancer. 2016 Oct 10;16(1):784. doi: 10.1186/s12885-016-2837-5. BMC Cancer. 2016. PMID: 27724924 Free PMC article.
-
MicroRNA-429 inhibits cancer cell proliferation and migration by targeting AKT1 in renal cell carcinoma.Mol Clin Oncol. 2020 Jan;12(1):75-80. doi: 10.3892/mco.2019.1940. Epub 2019 Oct 25. Mol Clin Oncol. 2020. PMID: 31814979 Free PMC article.
-
Combined microRNA-340 and ROCK1 mRNA profiling predicts tumor progression and prognosis in pediatric osteosarcoma.Int J Mol Sci. 2014 Jan 6;15(1):560-73. doi: 10.3390/ijms15010560. Int J Mol Sci. 2014. PMID: 24398981 Free PMC article.
-
Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma.Cancer Cell Int. 2015 Sep 17;15:86. doi: 10.1186/s12935-015-0237-6. eCollection 2015. Cancer Cell Int. 2015. Retraction in: Cancer Cell Int. 2016 Nov 4;16:84. doi: 10.1186/s12935-016-0359-5. PMID: 26388701 Free PMC article. Retracted.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical